Maarten Haspeslagh

Dr. Maarten Haspeslagh

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
MHMaarten Haspeslagh
Maarten Haspeslagh
LVLieven E. M. Vlaminck
Lieven E. M. Vlaminck
AMAnn M. Martens
Ann M. Martens
OBJECTIVE To evaluate outcomes following treatment of sarcoids in equids and to identify risk factors for treatment failure in these patients. DESIGN Retrospective case series. ANIMALS 230 equids with 614 sarcoids. PROCEDURES Records were searched to identify equids treated for ≥ 1 sarcoid between 2008 and 2013. A standardized protocol was used to determine treatment choice (electrosurgery, electrosurgery with intralesional placement of cisplatin-containing beads, topical administration of imiquimod or acyclovir, cryosurgery, bacillus Calmette-Guerin vaccine injection, or intralesional injection of platinum-containing drugs). Data regarding animal, tumor, treatment, and outcome variables were collected. Complete tumor regression without recurrence for ≥ 6 months was considered a successful outcome. Success rates were calculated; binary logistic regression analysis was used to identify risk factors for treatment failure and to compare effects of the 2 topical treatments. A χ2 test was used to compare effects of the number of Bacillus Calmette-Guerin vaccine or cisplatin-containing drug injections on outcome. RESULTS The overall success rate was 460 of 614 (74.9%). Electrosurgical excision resulted in the highest treatment success rate (277/319 [86.8%]); odds of treatment failure were significantly greater for intralesional injection of platinum-containing drugs, cryosurgery, and topical acyclovir treatment. Odds of treatment failure were also significantly greater for sarcoids on equids with multiple tumors than for solitary lesions, and significantly lower for sarcoids on equids that received concurrent immunostimulating treatment for another sarcoid than for those on patients that did not receive such treatment. CONCLUSIONS AND CLINICAL RELEVANCE Selection bias for treatments was inherent to the study design; however, results may assist clinicians in selecting treatments and in determining prognosis for equids with sarcoids treated according to the described methods.

1 November 2013 in Animal Welfare
Verified
Journal Article
Closed access
MHMaarten Haspeslagh
Maarten Haspeslagh
JSJmg Stevens
Jmg Stevens
EGE De Groot
E De Groot
JEROEN DEWULFJEROEN DEWULF
JEROEN DEWULF
IKId Kalmar
Id Kalmar
CMCph Moons
Cph Moons
This study investigates whether foot problems in captive Asian elephants(Elephas maximus)can be linked to: i) enclosure floor type; and ii) the occurrence of repetitive behaviour. Using a questionnaire, we collected information about floor type(s) in the enclosure, occurrence of repetitive behaviour and occurrence of foot problems for 87 Asian elephants (≥ 12 years) in 32 European zoos. The majority of elephants were housed on sand or concrete. A substantial proportion of the study population displayed repetitive behaviour. Respondents observed foot problems in 59 elephants, of which 53 displayed repetitive behaviour. Data analysis showed that elephants with access to sand flooring had a significantly greater chance of displaying stereotypic behaviour. Displaying this behaviour was also age-dependent with older elephants being more likely to do so. Furthermore, elephants that displayed stereotypic behaviour or that were being kept in an environment with sand or concrete flooring were more likely to have foot problems than others. Further research is required to determine whether the relationships between substrate, stereotypic behaviour and foot problems are of a causal nature.

16 October 2017 in Veterinary Surgery
Verified
Journal Article
Closed access
JBJulie Y. Brunsting
Julie Y. Brunsting
FPFrederik J. Pille
Frederik J. Pille
MOMaarten Oosterlinck
Maarten Oosterlinck
MHMaarten Haspeslagh
Maarten Haspeslagh
HWHans C. Wilderjans
Hans C. Wilderjans

1 October 2018 in The Veterinary Journal
Verified
Journal Article
Closed access
MHMaarten Haspeslagh
Maarten Haspeslagh
VGV. Gerber
V. Gerber
DKD.C. Knottenbelt
D.C. Knottenbelt
GSG. Schüpbach
G. Schüpbach
AMA. Martens
A. Martens
CKChristoph Koch
Christoph Koch

1 January 2018 in The Veterinary Journal
Verified
Journal Article
Closed access
MHMaarten Haspeslagh
Maarten Haspeslagh
LVL. Vlaminck
L. Vlaminck
AMA. Martens
A. Martens

1 December 2018 in The Veterinary Journal
Verified
Journal Article
Closed access
CKChristoph Koch
Christoph Koch
AMA. Martens
A. Martens
EHE.K. Hainisch
E.K. Hainisch
GSG. Schüpbach
G. Schüpbach
VGV. Gerber
V. Gerber
MHMaarten Haspeslagh
Maarten Haspeslagh